Dynocardia.Care

Dynocardia.Care is a provider of wearable devices for continuous and predictive remote patient monitoring, developing the ViTrack platform for accurate and continuous monitoring of blood pressure and other vital heart and lung functions. ViTrack is built on a proprietary technology platform that is fundamentally distinct from existing and emerging monitoring technologies, offering non-invasive continuous blood pressure measurement rather than intermittent cuff-based readings. The platform's potential applications span multiple markets including hospital acute care, clinical practice, remote patient monitoring, consumer wellness, and disease prevention. Dynocardia focuses on managing chronic conditions including hypertension, dementia, and sleep apnea, providing real-time insights for practitioners to manage patient health proactively. The ViTrack wearable and connected platform technology enables healthcare providers to monitor patients continuously, predict health deterioration, and intervene earlier, which the company positions as disruptive to multiple aspects of healthcare delivery. The company operates a clinical program to validate its technology and has received funding from federal sources. Founded in 2018 and headquartered in Cambridge, United States, the company has raised $6.1M in Series A funding from investors including Luminate and HHS.